Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +743.31%
#3 ADO Protocol ADO Protocol +101.16%
#4 Cortex Cortex +93.00%
#5 Ontology Gas Ontology Gas +74.97%
#6 Kinesis Silver Kinesis Silver +53.53%
#7 OpenEden OpenEden +37.48%
#8 Magma Finance Magma Finance +32.89%
#9 QuantixAI QuantixAI +23.21%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Flerie AB (publ) Flerie AB (publ)

Flerie AB (publ)

FLERIE
Rangering i aksjer #18881
Flerie AB (publ) functions as a venture capital entity, concentrating its... Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Aksjekurs
$2.11
Markedsverdi
$183.02M
Endring (1 dag)
-1.82%
Endring (1 år)
-45.27%
Land
SE
Handel Flerie AB (publ) (FLERIE)

Kategori

Healthcare
Utbytteavkastning for Flerie AB (publ) (FLERIE)
Flerie AB (publ) (aksjesymbol: FLERIE) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Flerie AB (publ) (FLERIE) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.57%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.01%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.74%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.47%
US